Vice President Marketing at SINTEF in Trondheim, Norway
Ruth Schmid is Vice President Marketing at SINTEF in Trondheim, Norway, with a special responsibility for the field of medical technology, including nanomedicine at SINTEF. She has undergraduate education in organic chemistry and a PhD in physical organic chemistry from ETH Zürich, Switzerland.
Ruth Schmid is the current chair of the European Technology Platform on Nanomedicine (ETPN) and a Past President of the Controlled Release Society (CRS).
Her present research activities include the preparation and characterisation of micro- and nanoparticles by various technologies and from a wide variety of materials (including biodegradable polymers and hybrid materials), as well as the surface modification of polymers and polymer particles by wet-chemistry, to introduce tailor-made properties. Lately, focus has been on the encapsulation and immobilisation of liquids and solids from emulsions, for protection and controlled release. Another focus has been on coating of biomaterials by self-assembling methods and covalent attachment with biocompatible, biomimetic and functional coatings, e.g. for introduction of antimicrobial properties, for increased osseo-integration or for immobilisation of biological molecules. Fields of special interest are the emerging fields of nanomedicine, targeted drug delivery and release, nanotechnology-based diagnostics, and regenerative medicine. Ruth Schmid has long-term experience in translation from lab to pilot scale, e.g. through the development of the Dynabeads. She has business development experience, e.g. SINTEFs various drug delivery platforms. Total number of peer reviewed publications: 63; citations 2031; h-index. 20